L-Norvaline, N-(1-oxobutyl)-, is a modified amino acid derivative characterized by the introduction of a butyryl group at the amine terminus of L-norvaline. This structural modification enhances its utility in peptide synthesis and biochemical research, where it serves as a versatile building block for designing specialized compounds. The product exhibits improved stability and solubility in organic solvents, facilitating its incorporation into complex molecular architectures. Its chiral purity ensures consistency in stereoselective applications, making it valuable for pharmaceutical and enzymatic studies. The butyryl side chain further allows for selective functionalization, expanding its potential in targeted drug development and proteomics research.